Immunologic significance of HLA class I genes in measles virus-specific IFN-γ and IL-4 cytokine immune responses
- 6 December 2005
- journal article
- research article
- Published by Springer Nature in Immunogenetics
- Vol. 57 (11) , 828-836
- https://doi.org/10.1007/s00251-005-0061-6
Abstract
The variability of immune responses modulated by human leukocyte antigen (HLA) genes and secreted cytokines is a significant factor in the development of a protective effect of measles vaccine. We studied the association between type 1 helper T cells (Th1)- and Th2-like cytokine immune responses and HLA class I alleles among 339 schoolchildren who previously received two doses of the measles vaccine. Median values for measles-specific interferon gamma (IFN-γ) and interleukin-4 (IL-4) cytokines were 40.7 pg/ml [interquartile range (IQR) 8.1–176.7] and 9.7 pg/ml (IQR 2.8–24.3), respectively. Class I HLA-A (*0101 and *3101) and HLA-Cw (*0303 and *0501) alleles were significantly associated with measles-virus-induced IFN-γ secretion. HLA-A*3101 and Cw*0303 were associated with a higher median IFN-γ response, while A*0101 and Cw*0501 were associated with lower measles-specific IFN-γ response. We found limited associations between HLA class I gene polymorphisms and Th2-like (IL-4) immune responses after measles vaccination, indicating that HLA class I molecules may have a limited effect on measles-vaccine-induced IL-4 secretion. Understanding the genetic factors that influence variations in cytokine secretion following measles vaccination will provide insight into the factors that influence both cell-mediated and humoral immunity to measles.Keywords
This publication has 48 references indexed in Scilit:
- The contribution of HLA class I antigens in immune status following two doses of rubella vaccinationHuman Immunology, 2004
- Humoral and Cell‐Mediated Immune Responses to an Early 2‐Dose Measles Vaccination Regimen in the United StatesThe Journal of Infectious Diseases, 2004
- Vigorous but Short-Term Gamma Interferon T-Cell Responses against a Dominant HLA-A*02-Restricted Measles Virus Epitope in Patients with MeaslesJournal of Virology, 2003
- Rapid Determination of HLA B*07 Ligands from the West Nile Virus NY99 GenomeEmerging Infectious Diseases, 2001
- Rapid Determination of HLA B*07 Ligands from the West Nile Virus NY99 GenomeEmerging Infectious Diseases, 2001
- A single naturally processed measles virus peptide fully dominates the HLA-A*0201-associated peptide display and is mutated at its anchor position in persistent viral strainsEuropean Journal of Immunology, 2000
- Cellular Immunity in Measles Vaccine Failure: Demonstration of Measles Antigen-Specific Lymphoproliferative Responses despite Limited Serum Antibody Production after RevaccinationThe Journal of Infectious Diseases, 1995
- Changes in Cytokine Production after Measles Virus Vaccination: Predominant Production of IL-4 Suggests Induction of a Th2 ResponseClinical Immunology and Immunopathology, 1993
- Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infectionClinical Immunology and Immunopathology, 1991
- HLA class II restriction repertoire of antigen-specific T cells. I. The main restriction determinants for antigen presentation are associated with HLA-D/DR and not with DP and DQHuman Immunology, 1985